Physician profile
Cheri Leng
NPI 1962473439
$803.20
in general payments reported to CMS, 2019-2025
10 companies · $48.65 in 2025
The $48.65 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $126 · 2021: $244 · 2022: $33.43 · 2023: $85.20 · 2024: $133 · 2025: $48.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $236.36 | 2019-2021 | |
| Glaukos Corporation | $173.66 | 2021-2025 | Idose, Istent Infinite, Idosetr |
| Novartis Pharmaceuticals Corporation | $109.79 | 2020 | |
| Abbvie INC. | $68.10 | 2024 | |
| Sight Sciences, INC. | $61.87 | 2021-2025 | Sion Surgical Instrument, Omni Surgical System |
| Rxsight INC | $47.97 | 2021-2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens |
| Alcon Vision LLC | $36.76 | 2020-2024 | Argos |
| Sun Pharmaceutical Industries INC. | $35.27 | 2019-2024 | |
| Dompe US, INC. | $18.54 | 2021 | |
| Biotissue Holdings INC. | $14.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheri Leng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.